What is George Poste’s total EXEL share ownership after this transaction?

Following the grant, George Poste directly beneficially owns 127,199 shares of EXEL common stock. This figure includes 8,367 shares that will be issued upon vesting of the restricted stock units, as specifically described in the ownership-related footnote to the filing.

Exelixis director granted 8,367 RSUs

POSTE GEORGE reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

POSTE GEORGE reported acquisition or exercise transactions in this Form 4 filing.

EXELIXIS, INC. director George Poste received a grant of 8,367 restricted stock units, each equal to one share of common stock and granted at no cost, under the company’s 2017 Equity Incentive Plan. The RSUs vest in full on May 27, 2027, subject to his continuous service. After this award, he directly beneficially owns 127,199 shares of common stock, including the unvested RSUs.

Insider Trade Summary

Grant/Award: 8,367 shares

Grant/Award 1 txn

Insider POSTE GEORGE

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,367	$0.00	$0.00

Holdings After Transaction: Common Stock — 127,199 shares (Direct)

Footnotes (2)

F1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.
F2. Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Key Figures

RSU grant size: 8,367 RSUs RSU grant price: $0.0000 per share Total shares after award: 127,199 shares +1 more

4 metrics

RSU grant size 8,367 RSUs Award of restricted stock units on May 27, 2026

RSU grant price $0.0000 per share Grant/award acquisition, compensation-related

Total shares after award 127,199 shares Direct beneficial ownership following the RSU grant

RSU vesting date May 27, 2027 100% of RSUs vest on this date if service continues

Key Terms

restricted stock units ("RSUs"), Exelixis, Inc. 2017 Equity Incentive Plan, continuous service

3 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Exelixis, Inc. 2017 Equity Incentive Plan financial

"granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan"

continuous service financial

"The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did EXEL (Exelixis, Inc.) director George Poste report on this Form 4?

George Poste reported receiving 8,367 restricted stock units in EXEL common stock as a compensation grant. The units were awarded at no cost and increase his direct beneficial holdings to 127,199 shares, including the unvested RSUs described in the filing’s footnotes.

How many EXEL shares did George Poste acquire through this Form 4 award?

The award covers 8,367 restricted stock units, each economically equal to one EXEL common share. These units will convert into common stock upon vesting, adding to Poste’s overall position if he remains in continuous service through the stated vesting date.

When do George Poste’s newly granted EXEL RSUs vest?

The 8,367 restricted stock units vest as to 100% of the shares on May 27, 2027. Vesting is conditioned on George Poste’s continuous service with Exelixis through that date, according to the terms described for this equity award in the filing’s footnotes.

Under which plan were George Poste’s EXEL restricted stock units granted?

The 8,367 restricted stock units were granted under the Exelixis, Inc. 2017 Equity Incentive Plan. This plan provides equity-based compensation such as RSUs, with each unit in this grant economically equivalent to one share of Exelixis common stock upon vesting and settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/29/2026 - 05:43 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POSTE GEORGE

(Last)

(First)

(Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA

CALIFORNIA

94502

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/27/2026		A		8,367⁽¹⁾	A	$0	127,199⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.

2. Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR